VivoSeq
Other

Adipokines

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Adipokines is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Completed4 · 100%

Clinical Trials

Trial Activity

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
Completed·—·N/A·NCT00486187·103 enrolled
Adipokines Effect in Myometrial Contractility
Completed·UUniversity of Minnesota·N/A·NCT03505541·60 enrolled
Phielix et al.: Hepatic Fat Content and Adipokines
Completed·GGerman Diabetes Center·N/A·NCT01570660·24 enrolled
Effects of Hypolipemic Treatment on Adipokines
Completed·MMedical University of Silesia·N/A·NCT01099176·78 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)